Medical Xpress July 9, 2024
Swiss pharmaceutical giant Roche said Tuesday it would soon begin marketing a device that uses artificial intelligence to predict possible low blood sugar events during the night and thus help sufferers of diabetes sleep without worry.
Diabetes is a chronic, metabolic disease characterized by elevated blood sugar levels that is treated with insulin injections. Sufferers can also have problems with episodes of low blood sugar levels—hypoglycaemia—during the night that disrupt their sleep, some requiring medical intervention.
Roche said its latest continuous glucose monitor, a wearable sensor, takes readings of blood sugar levels every five minutes and is paired with an AI app.
“Its integrated AI-enabled predictive algorithms indicate hypoglycaemia risk within the next 30 minutes, continuously forecast how glucose levels...
Today's Sponsors
Today's Sponsor